germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
obesity: 1‐year follow‐up.<br />
CLIN NUTR 2006; 25(3):400‐408.<br />
2,474<br />
Sierra JM, Sanchez F, Castro P, Salvado M, <strong>de</strong> la Red G, Libois A, Almela M, March F, Espanol M, Sambeat MA, Romeu J, Brugal<br />
MT, <strong>de</strong> Olalla PG, Gatell JM, Vila J, Garcia F, Colomes JLL, Calya JA, Coll P.<br />
Group A streptococcal infections in injection drug users in Barcelona, Spain ‐ Epi<strong>de</strong>miologic, clinical, and microbiologic analysis of<br />
3 clusters of cases from 2000 to 2003.<br />
MEDICINE 85(3):139‐146.<br />
5,167<br />
Siquier B, Sanchez‐Alvarez J, Garcia‐M<strong>en</strong><strong>de</strong>z E, Sabria M, Santos J, Pallares R, Twynholm M, Dal‐Re R; 620 Clinical Study Group.<br />
Efficacy and safety of twice‐daily pharmacokinetically <strong>en</strong>hanced amoxicillin/clavulanate (2000/125 mg) in the treatm<strong>en</strong>t of adults<br />
with community‐acquired pneumonia in a country with a high preval<strong>en</strong>ce of p<strong>en</strong>icillin‐resistant Streptococcus pneumoniae.<br />
J ANTIMICROB CHEMOTH 2006 Mar; 57(3):536‐45. Epub 2006 Jan 30<br />
3,891<br />
Sirera G, Vi<strong>de</strong>la S, Pinol M, Canadas MP, Llatjos M, Ballesteros AL, Garcia‐Cuyas F, Castella E, Guerola R, Tural C, Rey‐Joly C, Clotet<br />
B.<br />
High preval<strong>en</strong>ce of human papillomavirus infection in the anus, p<strong>en</strong>is and mouth in HIV‐positive m<strong>en</strong>.<br />
Aids 20(8):1201‐1204.<br />
5,632<br />
Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K, Prins M; CASCADE Collaboration.<br />
Effective therapy has altered the spectrum of cause‐specific mortality following HIV seroconversion.<br />
AIDS 2006 Mar 21;20(5):741‐9<br />
5,632<br />
Thiebaut R, Jacqmin‐Gadda H, Walker S, Sabin C, Prins M, Del Amo J, Porter K, Dabis F, Ch<strong>en</strong>e G; CASCADE Collaboration.<br />
Determinants of response to first HAART regim<strong>en</strong> in antiretroviral‐naive pati<strong>en</strong>ts with an estimated time since HIV<br />
seroconversion.<br />
HIV Med 2006 Jan;7(1):1‐9<br />
2,674<br />
Touloumi G, Pantazis N, Antoniou A, Stirna<strong>de</strong>l HA, Walker SA, Porter K; CASCADE Collaboration.<br />
Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequ<strong>en</strong>ces.<br />
JAIDS‐J ACQ IMM DEF 2006 Aug 15;42(5):554‐61<br />
3,946<br />
Urrutia A, Lupon J, Altimir S, Gonzalez B, Herreros J, Diez C, Coll R, Valle V, Rey‐Joly C.<br />
Use of betablockers in el<strong>de</strong>rly pati<strong>en</strong>ts with congestive heart failure.<br />
MED CLIN‐BARCELONA 126(6):206‐210.<br />
1,327<br />
Urrutia A, Lupon J, Altimir S, Gonzalez B, Herreros J, Diez C, Coll R, Valle V, Rey‐Joly C.<br />
Tratami<strong>en</strong>to <strong>de</strong> la insufici<strong>en</strong>cia cardíaca <strong>en</strong> paci<strong>en</strong>tes mayores <strong>de</strong> 75 años. Estudio comparativo con los paci<strong>en</strong>tes más jov<strong>en</strong>es.<br />
REV ESP GER GERON 2006; 41: 264‐9<br />
Youle M, Staszweski S, Clotet B, Arribas JR, Blaxhult A, Carosi G, DeJesus E, Di Perri G, Estrada V, Fisher M, Kovacs C, Kulasegaram<br />
R, Lazzarin A, Marriott D, Munoz L, Reynes J, Shalit P, Slim J, Tsoukas C, Vaccaro A, Vera J.<br />
Concomitant use of an active boosted protease inhibitor with <strong>en</strong>fuvirti<strong>de</strong> in treatm<strong>en</strong>t‐experi<strong>en</strong>ced, HIV‐infected individuals:<br />
Rec<strong>en</strong>t data and cons<strong>en</strong>sus recomm<strong>en</strong>dations.<br />
HIV CLIN TRIALS 2006 Mar‐Apr;7(2):86‐96<br />
1,704<br />
Pàgina 144/177